4//SEC Filing
Gandini David Joseph 4
Accession 0001582945-20-000005
CIK 0001425627other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 3:47 PM ET
Size
8.4 KB
Accession
0001582945-20-000005
Insider Transaction Report
Form 4
Gandini David Joseph
DirectorChief Revenue Officer
Transactions
- Award
Common Stock Option
2019-10-25+8,000,000→ 8,000,000 totalExercise: $0.01From: 2019-10-31Exp: 2029-10-31→ Common Stock (8,000,000 underlying) - Award
Common Stock Option
2019-10-25+24,000,000→ 32,000,000 totalExercise: $0.01From: 2019-11-25Exp: 2029-11-25→ Common Stock (24,000,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Reporting Person's Employment Agreement as the Issuer's Chief Revenue Officer, the Reporting Person was issued a stock option to acquire 8,000,000 shares of the Issuer's common stock at $0.00792 per share, with 6,666,600 options vesting on October 31, 2019 and 1,333,400 options vesting on December 31, 2019. The options expire 10 years after vesting.
- [F2]Pursuant to the Reporting Person's Employment Agreement, the Reporting Person was issued a stock option to acquire 24,000,000 shares of the Issuer's common stock at an exercise price of $0.00792 per share. The shares vest in equal monthly installments of 666,666 shares per month over 36 months and expire ten years from the vesting date.
Documents
Issuer
TransBiotec, Inc.
CIK 0001425627
Entity typeother
Related Parties
1- filerCIK 0001793420
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 3:47 PM ET
- Size
- 8.4 KB